Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arovella Therapeutics Ltd
Total Liabilities Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Total Liabilities
AU$2.1m
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Total Liabilities
AU$689m
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Total Liabilities
AU$9m
CAGR 3-Years
56%
CAGR 5-Years
47%
CAGR 10-Years
15%
Botanix Pharmaceuticals Ltd
ASX:BOT
Total Liabilities
AU$3.7m
CAGR 3-Years
48%
CAGR 5-Years
-4%
CAGR 10-Years
28%
Probiotec Ltd
ASX:PBP
Total Liabilities
AU$143.1m
CAGR 3-Years
11%
CAGR 5-Years
19%
CAGR 10-Years
14%
Vita Life Sciences Ltd
ASX:VLS
Total Liabilities
AU$19.2m
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
14%

See Also

What is Arovella Therapeutics Ltd's Total Liabilities?
Total Liabilities
2.1m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Total Liabilities amounts to 2.1m AUD.

What is Arovella Therapeutics Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-2%

Over the last year, the Total Liabilities growth was 22%. The average annual Total Liabilities growth rates for Arovella Therapeutics Ltd have been 6% over the past three years , -2% over the past five years .

Back to Top